4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-18-002512
Options or other derivatives
- Chief Executive Officer acquired 437,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Cohen Yuval · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-01-04 | Grant or award : show line 1 in the form Stock Option(right to buy) | +437,500 | $8.35 | 2028-01-04 | 437,500 | 437,500 | D |
Loading xslF345X03/doc4.xml…